Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

The Department investigates the molecular basis and signaling pathways associated with damage and repair in ischemic and inflammatory-based diseases associated with abdominal organs (liver, pancreas, and kidney), cancer, and cardiovascular disease but also other. idiopathic diseases such as pulmonary fibrosis.